drugset / Trial / NCT02315235

The Peripheral Mobilized Mononuclear Cell-based Therapy in Patient With Diabetic Neuropathy

NCT02315235

RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate the efficacy and safety of autologous peripheral blood stem cell based therapy in patients with diabetic painful neuropathy.

Timeline

Start
2014-05
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Stem Cell Cell therapy Intramuscular
Comparator Granulocyte colony-stimulating factor Protein / enzyme biologic Subcutaneous

Indications